Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.
Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.
Displaying 42727 questions Show Answers
To ask the Scottish Government what urgent steps it is taking in light of reports that nearly one in five people abandoned their call to NHS 24 in 2024.
To ask the Scottish Government, in relation to its public service reform programme, what proportion of its planned £280 million savings by the end of 2024-25 will have come from reductions in pay costs for the board members of (a) public sector and (b) other non-departmental bodies.
To ask the Scottish Government how many people have been prosecuted under the Dog Fouling (Scotland) Act 2003 in each year since 2010.
To ask the Scottish Government what its response is to reported findings from a survey by Aberdeen and Grampian Chamber of Commerce that more than two thirds of voters want the UK and Scottish governments to adopt a "pragmatic, domestic-first approach" to energy.
To ask the Scottish Government what plans it has to establish a working group to investigate and consider any health impact on women due to exposure to diethylstilbestrol (DES).
To ask the Scottish Government how many compensation payments for wrongful imprisonment have been made in each of the last 10 years.
To ask the Scottish Government whether it will ensure that there is (a) a specific focus on and (b) accompanying ringfenced funding for kidney disease in the forthcoming long-term conditions framework.
To ask the Scottish Government for what reason it spent £2,609.78 on belongto.org on 12 March 2025.
To ask the Scottish Government whether any costing or modelling has been done to deliver its commitment to reduce teacher class contact time.
To ask the Scottish Government what COVID-19 vaccines are available for those who are immunocompromised and have a respiratory illness, in light of reports that VidPrevtyn, manufactured by Sanofi Paseur, is no longer available.